A multicentre, comparative, controlled, open label, randomized, parallel-group, phase III study to evaluate the safety and efficacy of fixed dose combination containing rosuvastatin calcium with ezetimibe versus monotherapy in dyslipidemic patients

Trial Profile

A multicentre, comparative, controlled, open label, randomized, parallel-group, phase III study to evaluate the safety and efficacy of fixed dose combination containing rosuvastatin calcium with ezetimibe versus monotherapy in dyslipidemic patients

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Aug 2016

At a glance

  • Drugs Ezetimibe/rosuvastatin (Primary) ; Ezetimibe; Rosuvastatin
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Sponsors Biocon
  • Most Recent Events

    • 08 Feb 2011 New trial record
    • 02 Feb 2011 Status changed from not yet recruiting to recruiting, according to the India Clinical Trials register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top